Amino acid substitution in hepatitis C virus core region and genetic variation near the interleukin 28B gene predict viral response to telaprevir with peginterferon and ribavirin

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Norio AkutaHiromitsu Kumada

Abstract

Genetic variation near the IL28B gene and substitution of amino acid (aa) 70 and 91 in the core region of hepatitis C virus (HCV) genotype 1b can predict the response to pegylated interferon (PEG-IFN)/ribavirin combination therapy, but its impact on triple therapy of telaprevir/PEG-IFN/ribavirin is not clear. The aims of this study were to investigate the predictive factors of sustained virological response to a 12-week or 24-week regimen of triple therapy in 72 of 81 Japanese adults infected with HCV genotype 1. Overall, sustained virological response and end-of-treatment response were achieved by 61% and 89%, respectively. Especially, the sustained virological response was achieved by 45% and 67% in the 12- and 24-week regimens, respectively. Multivariate analysis identified rs8099917 near the IL28B gene (genotype TT) and substitution at aa 70 (Arg70) as significant determinants of sustained virological response. Prediction of response to therapy based on a combination of these factors had high sensitivity, specificity, and positive and negative predictive values. The efficacy of triple therapy was high in the patients with genotype TT, who accomplished sustained virological response (84%), irrespective of substitution of cor...Continue Reading

References

Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·N KatoK Shimotohno
Nov 26, 1998·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·C NiederauD Häussinger
Aug 15, 2001·Journal of Human Genetics·Y OhnishiY Nakamura
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Dec 7, 2002·Nature Immunology·Paul SheppardKevin M Klucher
Dec 17, 2002·Nature Immunology·Sergei V KotenkoRaymond P Donnelly
Feb 26, 2005·Journal of Virology·Michael D RobekFrancis V Chisari
Sep 9, 2005·Virology Journal·Haizhen ZhuChen Liu
Jul 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Norio AkutaHiromitsu Kumada
Aug 8, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tara L KiefferStefan Zeuzem
Sep 20, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Apurva A Modi, Jay H Hoofnagle
Sep 20, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nicole ForestierStefan Zeuzem
Jun 10, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ahmed El-ShamyHak Hotta
Apr 23, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sarah L FishmanAndrea D Branch
May 1, 2009·The New England Journal of Medicine·John G McHutchisonUNKNOWN PROVE1 Study Team
May 1, 2009·The New England Journal of Medicine·Christophe HézodeUNKNOWN PROVE2 Study Team
Sep 15, 2009·Nature Genetics·Vijayaprakash SuppiahJacob George
Sep 18, 2009·Nature·David L ThomasMary Carrington

❮ Previous
Next ❯

Citations

Nov 17, 2010·Current Gastroenterology Reports·Brian L Pearlman
Apr 7, 2011·Nature Reviews. Gastroenterology & Hepatology·Wolf Peter Hofmann, Stefan Zeuzem
May 30, 2012·Nature Reviews. Gastroenterology & Hepatology·C Nelson HayesKazuaki Chayama
Nov 30, 2011·The Journal of Infectious Diseases·Hidenori OchiKazuaki Chayama
Dec 24, 2011·The Journal of Antimicrobial Chemotherapy·Vincent SorianoPablo Barreiro
Apr 1, 2011·Current Opinion in Gastroenterology·Vincent Zimmer, Frank Lammert
Jul 5, 2011·Journal of Gastroenterology and Hepatology·José M LaderoJosé A Agúndez
Jul 21, 2012·Journal of Clinical Microbiology·Kok Siong PoonEvelyn Siew-Chuan Koay
Nov 28, 2012·BMC Infectious Diseases·Stefania NucaraFrancesco Trapasso
Feb 19, 2014·Genome Medicine·Kazuaki Chayama, C Nelson Hayes
Sep 21, 2011·PLoS Medicine·Vijayaprakash SuppiahUNKNOWN International Hepatitis C Genetics Consortium (IHCGC)
Jul 16, 2011·PloS One·Thomas R O'BrienUNKNOWN HALT-C Trial Group
Jan 25, 2013·Viruses·Monika RauAndreas Geier
Jan 1, 2014·World Journal of Gastroenterology : WJG·Yan Zhu, Song Chen
Sep 12, 2012·World Journal of Gastrointestinal Pharmacology and Therapeutics·Marco CarboneLeonardo Baiocchi
Mar 25, 2014·World Journal of Gastroenterology : WJG·Nikolaos K GatselisGeorge N Dalekos
May 9, 2014·International Journal of Nanomedicine·Chen-Hua Liu, Jia-Horng Kao
Sep 15, 2011·Immunotherapy·Aarthi Chary, Mark Holodniy
Apr 9, 2011·Biomarkers in Medicine·Julia SchmidtChristoph Neumann-Haefelin
Aug 25, 2011·Biomarkers in Medicine·Jacinta A HolmesAlexander J Thompson
Oct 25, 2012·Hepatitis Research and Treatment·David R NelsonDavid Thomas
Jun 2, 2014·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·Masanori AtsukawaChoitsu Sakamoto
Jul 17, 2010·Journal of Gastroenterology·Golo AhlenstielJacob George
May 17, 2012·Journal of Gastroenterology·Yasuteru KondoTooru Shimosegawa
Oct 30, 2012·Journal of Gastroenterology·Wan-Long Chuang, Ming-Lung Yu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.